UNSPSC 51373312: Acetaminophen/hydrocodone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373312 Acetaminophen/hydrocodone, a Commodity code, covers individual pharmaceutical products that state and local governments procure through health agencies, county health departments, and cooperative purchasing alliances. The recent opportunities show state and local buyers acquiring naloxone, generic multi-source pharmaceuticals, and over-the-counter products for distribution through authorized wholesalers and direct delivery to county health facilities. Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance, serving participating state and local jurisdictions in Minnesota and Oregon). The procurement mix spans emergency-response pharmaceuticals, generic drug programs distributed through established wholesale channels, and direct-to-manufacturer prescription initiatives that bypass traditional pharmacy benefit managers.

Recent activity concentrates in Florida, Texas, and the Minnesota–Oregon cooperative region. Seminole County, Florida posted IFB60459723LAS on June 30, 2026, for 1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually, due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building; vendors must include shipping and delivery costs in their bids and comply with E-Verify and workers' compensation requirements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (S1070000015802) on January 20, 2026, for generic multi-source pharmaceuticals and OTC products, closing March 26, 2026; vendors must supply through three authorized wholesalers and demonstrate cGMP certification and Drug Supply Chain Security Act compliance, with awards effective July 1, 2026. The Texas Health and Human Services Commission posted a Request for Information (HHS0017013) on April 3, 2026, to explore vendor capacity for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements, framing future formal procurement design.